We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 1880L
GlaxoSmithKline PLC
04 September 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== =========================================================================================== a) Name Ms D Conrad ==== ======================================== ================================================= b) Position/status SVP, Human Resources ==== ======================================== ================================================= c) Initial notification/ Initial notification amendment ==== ======================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== =========================================================================================== a) Name GlaxoSmithKline plc ==== ======================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== =========================================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================== ================================================= b) Nature of the Purchase of ADSs jointly with Mr C J Conrad, transaction a PCA. ==== ======================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ===================== ======================= $41.75 1,800 ===================== ======================= d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= ===================================================== e) Date of the transaction 2019-08-30 ==== ======================================== ================================================= f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ========================================================================================= a) Name Mr C J Conrad ==== ======================================== =============================================== b) Position/status PCA of Ms D Conrad (SVP, Human Resources) ==== ======================================== =============================================== c) Initial notification/ Initial notification amendment ==== ======================================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ======================================== =============================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================== =============================================== b) Nature of the Purchase of ADSs jointly with Ms D Conrad, transaction a PDMR. ==== ======================================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ==================== ====================== $41.75 1,800 ==================== ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= =================================================== e) Date of the transaction 2019-08-30 ==== ======================================== =============================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ===============================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHVZLBBKKFXBBB
(END) Dow Jones Newswires
September 04, 2019 04:33 ET (08:33 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions